Recently, the review Inflammation and Tumor Progression: Signaling Pathways and Targeted Intervention published by the team of Li Yongsheng and Wu Yongzhong from Chongqing University Cancer Hospital won the 2022 Annual Best Paper Award of Signal Transduction and Targeted Therapy.
It is reported that this review was published in July 2021. According to the latest data released by Clarivate Analytics, it has been cited more than 214 times and downloaded more than 36,000 times in one year, scored 27 points in Altmetric and was selected as a hot topic paper and a highly cited paper in ESI.
From the initiation and regression of inflammation, this review expounds the complex relationship between inflammation and tumor formation, development and treatment, describes the inflammation types that respectively promote cancer and inhibit cancer and also discusses the intervention strategies for targeted regulation of inflammation in tumor treatment. Zhao Huakan, Wu Lei, Yan Guifang, Zhou Mingyue and Chen Yu from the Department of Oncology, Chongqing University Cancer Hospital are the co-first authors of the paper, and Professors Li Yongsheng and Wu Yongzhong are the co-corresponding authors. The review has a total of 50,000 words, citing 906 references.
Signal Transformation and Targeted Therapy (STTT) is a high-level English journal in China, which is jointly organized by West China Hospital/State Key Laboratory of Biotherapy, Sichuan University and Springer-Nature. It belongs to the top journal in CAS Q1 and has been listed in the leading project of China's Excellent Action Plan of Sci-tech Journals, with the latest impact factor of 38.104. The Annual Best Paper Award is granted to 10 best papers evaluated by STTT every year according to the citation, downloading and reprinting of all papers it collected in the previous year, which is widely representative and objective.